Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 621

1.

Nipah shell disorder, modes of infection, and virulence.

Goh GK, Dunker AK, Foster JA, Uversky VN.

Microb Pathog. 2020 Jan 12;141:103976. doi: 10.1016/j.micpath.2020.103976. [Epub ahead of print]

PMID:
31940461
2.

Nucleation-dependent amyloid fibrillation of human GRASP55 in aqueous solution.

Reddy ST, Uversky VN, Costa-Filho AJ.

Eur Biophys J. 2020 Jan 8. doi: 10.1007/s00249-019-01419-7. [Epub ahead of print]

PMID:
31915857
3.

Liquid-liquid phase separation and fibrillation of the prion protein modulated by a high-affinity DNA aptamer.

Matos CO, Passos YM, do Amaral MJ, Macedo B, Tempone MH, Bezerra OCL, Moraes MO, Almeida MS, Weber G, Missailidis S, Silva JL, Uversky VN, Pinheiro AS, Cordeiro Y.

FASEB J. 2020 Jan;34(1):365-385. doi: 10.1096/fj.201901897R. Epub 2019 Nov 22.

PMID:
31914616
4.

Granulins modulate liquid-liquid phase separation and aggregation of prion-like C-terminal domain of the neurodegeneration-associated protein TDP-43.

Bhopatkar AA, Uversky VN, Rangachari V.

J Biol Chem. 2020 Jan 6. pii: jbc.RA119.011501. doi: 10.1074/jbc.RA119.011501. [Epub ahead of print]

5.

Intrinsic Disorder-Based Design of Stable Globular Proteins.

Nagibina GS, Glukhova KA, Uversky VN, Melnik TN, Melnik BS.

Biomolecules. 2019 Dec 30;10(1). pii: E64. doi: 10.3390/biom10010064.

6.

Epitope Region Identification Challenges of Intrinsically Disordered Proteins in Neurodegenerative Diseases: Secondary Structure Dependence of α-Synuclein on Simulation Techniques and Force Field Parameters.

Mandaci SY, Caliskan M, Sariaslan MF, Uversky VN, Coskuner-Weber O.

Chem Biol Drug Des. 2020 Jan 6. doi: 10.1111/cbdd.13662. [Epub ahead of print]

PMID:
31903719
7.

The dark side of Alzheimer's disease: unstructured biology of proteins from the amyloid cascade signaling pathway.

Gadhave K, Gehi BR, Kumar P, Xue B, Uversky VN, Giri R.

Cell Mol Life Sci. 2020 Jan 2. doi: 10.1007/s00018-019-03414-9. [Epub ahead of print]

PMID:
31894361
8.

Life in Phases: Intra- and Inter- Molecular Phase Transitions in Protein Solutions.

Uversky VN, Finkelstein AV.

Biomolecules. 2019 Dec 8;9(12). pii: E842. doi: 10.3390/biom9120842. Review.

9.

Evolutionary Analyses of Sequence and Structure Space Unravel the Structural Facets of SOD1.

Chowdhury S, Sanyal D, Sen S, Uversky VN, Maulik U, Chattopadhyay K.

Biomolecules. 2019 Dec 4;9(12). pii: E826. doi: 10.3390/biom9120826.

10.

Rational discovery of antimetastatic agents targeting the intrinsically disordered region of MBD2.

Kim MY, Na I, Kim JS, Son SH, Choi S, Lee SE, Kim JH, Jang K, Alterovitz G, Chen Y, van der Vaart A, Won HS, Uversky VN, Kim CG.

Sci Adv. 2019 Nov 20;5(11):eaav9810. doi: 10.1126/sciadv.aav9810. eCollection 2019 Nov.

11.

Many-to-one binding by intrinsically disordered protein regions.

Alterovitz WL, Faraggi E, Oldfield CJ, Meng J, Xue B, Huang F, Romero P, Kloczkowski A, Uversky VN, Dunker AK.

Pac Symp Biocomput. 2020;25:159-170.

12.

Characterization of an Extensive Interface on Vitronectin for Binding to Plasminogen Activator Inhibitor-1: Adoption of Structure in an Intrinsically Disordered Region.

Puster LO, Stanley CB, Uversky VN, Curtis JE, Krueger S, Chu Y, Peterson CB.

Biochemistry. 2019 Dec 24;58(51):5117-5134. doi: 10.1021/acs.biochem.9b00605. Epub 2019 Dec 16.

PMID:
31793295
13.

Comprehensive analysis of the molecular docking of small molecule inhibitors to the Aβ1-40 peptide and its Osaka-mutant: insights into the molecular mechanisms of Aβ-peptide inhibition.

Salahuddin P, Khan RH, Uversky VN.

J Biomol Struct Dyn. 2019 Dec 9:1-31. doi: 10.1080/07391102.2019.1697367. [Epub ahead of print]

PMID:
31779527
14.

Expanding the understanding of the heterogeneous nature of melanoma with bioinformatics and disorder-based proteomics.

Djulbegovic MB, Uversky VN.

Int J Biol Macromol. 2019 Nov 16. pii: S0141-8130(19)35074-3. doi: 10.1016/j.ijbiomac.2019.10.139. [Epub ahead of print] Review.

PMID:
31743721
15.

Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma.

Chobrutskiy BI, Yeagley M, Tipping P, Zaman S, Diviney A, Patel DN, Falasiri S, Uversky VN, Blanck G.

Oncogene. 2019 Nov 18. doi: 10.1038/s41388-019-1101-2. [Epub ahead of print]

PMID:
31740784
16.

Understanding the penetrance of intrinsic protein disorder in rotavirus proteome.

Kumar D, Singh A, Kumar P, Uversky VN, Rao CD, Giri R.

Int J Biol Macromol. 2019 Nov 15. pii: S0141-8130(19)35020-2. doi: 10.1016/j.ijbiomac.2019.09.166. [Epub ahead of print]

PMID:
31739058
17.

Folding perspectives of an intrinsically disordered transactivation domain and its single mutation breaking the folding propensity.

Sharma N, Fonin AV, Shpironok OG, Silonov SA, Turoverov KK, Uversky VN, Kuznetsova IM, Giri R.

Int J Biol Macromol. 2019 Nov 13. pii: S0141-8130(19)34479-4. doi: 10.1016/j.ijbiomac.2019.11.111. [Epub ahead of print]

PMID:
31733244
18.

Zika and Flavivirus Shell Disorder: Virulence and Fetal Morbidity.

Goh GK, Dunker AK, Foster JA, Uversky VN.

Biomolecules. 2019 Nov 6;9(11). pii: E710. doi: 10.3390/biom9110710.

19.

Targeting the NTPase site of Zika virus NS3 helicase for inhibitor discovery.

Kumar D, Aarthy M, Kumar P, Singh SK, Uversky VN, Giri R.

J Biomol Struct Dyn. 2019 Nov 14:1-11. doi: 10.1080/07391102.2019.1689851. [Epub ahead of print]

PMID:
31690231
20.

Development of a MEL Cell-Derived Allograft Mouse Model for Cancer Research.

Kim MY, Choi S, Lee SE, Kim JS, Son SH, Lim YS, Kim BJ, Ryu BY, Uversky VN, Lee YJ, Kim CG.

Cancers (Basel). 2019 Nov 1;11(11). pii: E1707. doi: 10.3390/cancers11111707.

Supplemental Content

Loading ...
Support Center